Enliven Therapeutics, Inc.
ELVN
DELAYED 1 MONTH

4 insider filings · Latest: Jun 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 5, 2026Jun 9 8:49 PMLori Anne KunkelDirector
Sale
10,000$34.54$345.4K51,884(D)

View →

May 18, 2026May 20 8:18 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Sale
5,000$39.79$199.0K25,000(D)

View →

Mar 10, 2026Mar 11 9:32 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Sale
10,129$30.19$305.8K25,000(D)

View →

Mar 9, 2026Mar 11 9:32 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Sale
29,871$30.02$896.8K25,000(D)

View →

Mar 6, 2026Mar 10 10:15 PMBenjamin HohlCHIEF FINANCIAL OFFICER
Sale
10,000$29.58$295.8K51,000(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 18, 2026May 20 8:18 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48126,268(D)

View →

Mar 10, 2026Mar 11 9:32 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
10,129$2.48181,268(D)

View →

Mar 9, 2026Mar 11 9:32 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
29,871$2.48191,397(D)

View →